Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

Documenti analoghi

• The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
  di: Parameswaran K. Nair, et al.
  Pubblicazione: (2025)
• Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis
  di: Alvise Berti, et al.
  Pubblicazione: (2026)
• Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort
  di: Matthias Papo, et al.
  Pubblicazione: (2026)
• Trimethoprim/Sulfamethoxazole in Clinical Trials for Granulomatosis With Polyangiitis
  di: Jan Willem Cohen Tervaert
  Pubblicazione: (2025)
• A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis
  di: Carol A. Langford, et al.
  Pubblicazione: (2025)